US6096318A
(en)
|
1973-05-07 |
2000-08-01 |
The Ohio State University |
Antigenically modified HCG polypeptides
|
US4902506A
(en)
|
1983-07-05 |
1990-02-20 |
The University Of Rochester |
Immunogenic conjugates
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US5158769A
(en)
|
1984-03-07 |
1992-10-27 |
New York Blood Center, Inc. |
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
|
US5417986A
(en)
|
1984-03-16 |
1995-05-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US5208036A
(en)
|
1985-01-07 |
1993-05-04 |
Syntex (U.S.A.) Inc. |
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US4666829A
(en)
|
1985-05-15 |
1987-05-19 |
University Of California |
Polypeptide marker for Alzheimer's disease and its use for diagnosis
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
US4713366A
(en)
|
1985-12-04 |
1987-12-15 |
The Ohio State University Research Foundation |
Antigenic modification of polypeptides
|
US5096706A
(en)
|
1986-03-25 |
1992-03-17 |
National Research Development Corporation |
Antigen-based treatment for adiposity
|
US6548640B1
(en)
|
1986-03-27 |
2003-04-15 |
Btg International Limited |
Altered antibodies
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US5278049A
(en)
|
1986-06-03 |
1994-01-11 |
Incyte Pharmaceuticals, Inc. |
Recombinant molecule encoding human protease nexin
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
US5220013A
(en)
|
1986-11-17 |
1993-06-15 |
Scios Nova Inc. |
DNA sequence useful for the detection of Alzheimer's disease
|
US5187153A
(en)
|
1986-11-17 |
1993-02-16 |
Scios Nova Inc. |
Methods of treatment using Alzheimer's amyloid polypeptide derivatives
|
US5223482A
(en)
|
1986-11-17 |
1993-06-29 |
Scios Nova Inc. |
Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
|
US4879213A
(en)
|
1986-12-05 |
1989-11-07 |
Scripps Clinic And Research Foundation |
Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
|
US4912206A
(en)
|
1987-02-26 |
1990-03-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
CDNA clone encoding brain amyloid of alzheimer's disease
|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2 Inc |
Geänderte antikörper.
|
US4883666A
(en)
|
1987-04-29 |
1989-11-28 |
Massachusetts Institute Of Technology |
Controlled drug delivery system for treatment of neural disorders
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US5245015A
(en)
|
1991-04-26 |
1993-09-14 |
Tanox Biosystems, Inc. |
Monoclonal antibodies which neutralize HIV-1 through reaction with a conformational epitope in vitro
|
US5583112A
(en)
|
1987-05-29 |
1996-12-10 |
Cambridge Biotech Corporation |
Saponin-antigen conjugates and the use thereof
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US5849298A
(en)
|
1987-06-24 |
1998-12-15 |
Autoimmune Inc. |
Treatment of multiple sclerosis by oral administration of bovine myelin
|
US5571499A
(en)
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
ATE258065T1
(de)
|
1987-06-24 |
2004-02-15 |
Brigham & Womens Hospital |
Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
|
US5645820A
(en)
|
1987-06-24 |
1997-07-08 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US5869054A
(en)
|
1987-06-24 |
1999-02-09 |
Autoimmune Inc. |
Treatment of multiple sclerosis by oral administration of autoantigens
|
US5641474A
(en)
|
1987-06-24 |
1997-06-24 |
Autoimmune, Inc. |
Prevention of autoimmune diseases by aerosol administration of autoantigens
|
US5571500A
(en)
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases through administration by inhalation of autoantigens
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
CA1339014C
(en)
|
1987-10-08 |
1997-03-25 |
Ronald E. Majocha |
Antibodies to a4 amyloid peptide
|
US5231000A
(en)
|
1987-10-08 |
1993-07-27 |
The Mclean Hospital |
Antibodies to A4 amyloid peptide
|
JP2518911B2
(ja)
|
1987-10-23 |
1996-07-31 |
森永乳業株式会社 |
c―fms癌原遺伝子の過剰発現によって特徴づけられた癌の処置用組成物および方法
|
US5089603A
(en)
|
1989-06-21 |
1992-02-18 |
Tanox Biosystems, Inc. |
Antigenic epitopes present on membrane-bound but not secreted iga
|
WO1989006689A1
(en)
|
1988-01-13 |
1989-07-27 |
The Mclean Hospital Corporation |
Genetic constructs containing the alzheimer brain amyloid gene
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
US5576184A
(en)
|
1988-09-06 |
1996-11-19 |
Xoma Corporation |
Production of chimeric mouse-human antibodies with specificity to human tumor antigens
|
EP0442926A1
(en)
|
1988-11-10 |
1991-08-28 |
Imperial Cancer Research Technology Limited |
Polypeptides
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5227159A
(en)
|
1989-01-31 |
1993-07-13 |
Miller Richard A |
Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
|
US5262332A
(en)
|
1989-04-05 |
1993-11-16 |
Brigham And Women's Hospital |
Diagnostic method for Alzheimer's disease: examination of non-neural tissue
|
WO1990012870A1
(en)
|
1989-04-14 |
1990-11-01 |
Research Foundation For Mental Hygiene, Inc. |
Monoclonal antibody to amyloid peptide
|
WO1990012871A1
(en)
|
1989-04-14 |
1990-11-01 |
Research Foundation For Mental Hygiene, Inc. |
Cerebrovascular amyloid protein-specific monoclonal antibody sv17-6e10
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
AU642693B2
(en)
|
1989-12-20 |
1993-10-28 |
Autoimmune, Inc. |
Improved treatment of autoimmune diseases by aerosol administration of auto antigens
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
ATE356869T1
(de)
|
1990-01-12 |
2007-04-15 |
Amgen Fremont Inc |
Bildung von xenogenen antikörpern
|
CA2077340A1
(en)
|
1990-03-02 |
1991-09-03 |
Howard L. Weiner |
Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens
|
WO1991016628A1
(en)
|
1990-04-24 |
1991-10-31 |
The Regents Of The University Of California |
Purification, detection and methods of use of protease nexin-2
|
WO1991016819A1
(en)
|
1990-04-27 |
1991-11-14 |
Molecular Rx., Inc. |
Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein
|
GB9009548D0
(en)
|
1990-04-27 |
1990-06-20 |
Celltech Ltd |
Chimeric antibody and method
|
US5753624A
(en)
|
1990-04-27 |
1998-05-19 |
Milkhaus Laboratory, Inc. |
Materials and methods for treatment of plaquing disease
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
ES2217250T3
(es)
|
1990-06-15 |
2004-11-01 |
Scios Inc. |
Mamifero transgenico, no humano que muestra la patologia de formacion amiloides de la enfermedad de alzheimer.
|
WO1991019795A1
(en)
|
1990-06-19 |
1991-12-26 |
Immuvax |
Nonpathogenic variant virus
|
GB9014932D0
(en)
|
1990-07-05 |
1990-08-22 |
Celltech Ltd |
Recombinant dna product and method
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US5780587A
(en)
|
1990-08-24 |
1998-07-14 |
President And Fellows Of Harvard College |
Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
|
NZ239643A
(en)
|
1990-09-17 |
1996-05-28 |
North American Vaccine Inc |
Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
|
US6506728B2
(en)
|
1990-09-25 |
2003-01-14 |
Genentech, Inc. |
Methods using a novel neurotrophic factor, NT-4
|
EP0550675A1
(en)
|
1990-09-28 |
1993-07-14 |
Cephalon, Inc. |
Transgenic animals with alzheimer's amyloid precursor gene
|
AU667460B2
(en)
|
1990-10-05 |
1996-03-28 |
Medarex, Inc. |
Targeted immunostimulation with bispecific reagents
|
IL99754A
(en)
|
1990-10-15 |
1996-08-04 |
Autoimmune Inc |
Pharmaceutical preparation containing autoantib or particle or analogue for the treatment of autoimmune arthritis and multiple sclerosis
|
GB9023352D0
(en)
|
1990-10-26 |
1990-12-05 |
Lynxvale Ltd |
Vaccinia vectors,vaccinia genes and expression products thereof
|
DE69233468T3
(de)
|
1991-01-21 |
2011-05-05 |
Elan Pharmaceuticals, Inc., San Francisco |
Prüfung und modell für alzheimers-krankheit
|
PL296623A1
(en)
|
1991-03-01 |
1993-09-20 |
Rhone Merieux |
Method of improving organoleptic properties of male slaughter animal meat
|
US5192753A
(en)
|
1991-04-23 |
1993-03-09 |
Mcgeer Patrick L |
Anti-rheumatoid arthritic drugs in the treatment of dementia
|
JPH06500128A
(ja)
|
1991-05-08 |
1994-01-06 |
シュバイツ・ゼルム―・ウント・インプフィンスティテュート・ベルン |
免疫刺激及び免疫増強性再構成インフルエンザウイロソーム及びそれを含有するワクチン
|
LU91067I2
(fr)
|
1991-06-14 |
2004-04-02 |
Genentech Inc |
Trastuzumab et ses variantes et dérivés immuno chimiques y compris les immotoxines
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
US5672805A
(en)
|
1991-07-18 |
1997-09-30 |
The Regents Of The University Of California |
Transgenic mice expressing the neurotoxic C-terminus of β-amyloid precursor protein
|
US5434050A
(en)
|
1991-08-13 |
1995-07-18 |
Regents Of The University Of Minnesota |
Labelled β-amyloid peptide and methods of screening for Alzheimer's disease
|
US5837268A
(en)
|
1991-10-16 |
1998-11-17 |
University Of Saskatchewan |
GnRH-leukotoxin chimeras
|
EP0746609A4
(en)
|
1991-12-17 |
1997-12-17 |
Genpharm Int |
NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
|
WO1993014200A1
(en)
|
1992-01-07 |
1993-07-22 |
Tsi Corporation |
Transgenic animal models for alzheimer's disease
|
US5679348A
(en)
|
1992-02-03 |
1997-10-21 |
Cedars-Sinai Medical Center |
Immunotherapy for recurrent HSV infections
|
EP1958646A1
(en)
|
1992-02-11 |
2008-08-20 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
ATE228373T1
(de)
|
1992-02-28 |
2002-12-15 |
Autoimmune Inc |
Unterdrückung von autoimmunkrankheiten durch antigene in wartestellung
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
US5441870A
(en)
|
1992-04-15 |
1995-08-15 |
Athena Neurosciences, Inc. |
Methods for monitoring cellular processing of β-amyloid precursor protein
|
US5604102A
(en)
|
1992-04-15 |
1997-02-18 |
Athena Neurosciences, Inc. |
Methods of screening for β-amyloid peptide production inhibitors
|
US5851787A
(en)
|
1992-04-20 |
1998-12-22 |
The General Hospital Corporation |
Nucleic acid encoding amyloid precursor-like protein and uses thereof
|
CA2118508A1
(en)
|
1992-04-24 |
1993-11-11 |
Elizabeth S. Ward |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
GB9209118D0
(en)
|
1992-04-28 |
1992-06-10 |
Sb 120 Amsterdam Bv |
Vaccine compositions
|
AU671649B2
(en)
|
1992-06-18 |
1996-09-05 |
President And Fellows Of Harvard College |
Diphtheria toxin vaccines
|
RU2118164C1
(ru)
|
1992-06-25 |
1998-08-27 |
Смитклайн Бичам Байолоджикалс, С.А. |
Вакцинная композиция, обладающая свойством вызывать цитолитический т-клеточный ответ у млекопитающих, способ получения цитолитического т-клеточного ответа in vivo, способ получения вакцины
|
US6610493B1
(en)
|
1993-06-17 |
2003-08-26 |
Brigham And Women's Hospital |
Screening compounds for the ability to alter the production of amyloid-β peptide
|
US5837672A
(en)
|
1992-07-10 |
1998-11-17 |
Athena Neurosciences, Inc. |
Methods and compositions for the detection of soluble β-amyloid peptide
|
US5766846A
(en)
|
1992-07-10 |
1998-06-16 |
Athena Neurosciences |
Methods of screening for compounds which inhibit soluble β-amyloid peptide production
|
WO1994001772A1
(en)
|
1992-07-13 |
1994-01-20 |
The Children's Medical Center Corporation |
SCREEN FOR ALZHEIMER'S DISEASE THERAPEUTICS BASED ON β-AMYLOID PRODUCTION
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
US6680182B1
(en)
|
1992-07-31 |
2004-01-20 |
Acambis Research Limited |
Expression of recombinant fusion proteins in attenuated bacteria
|
BR9306984A
(pt)
|
1992-08-27 |
1999-01-12 |
Deakin Res Ltd |
Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
|
US5958883A
(en)
|
1992-09-23 |
1999-09-28 |
Board Of Regents Of The University Of Washington Office Of Technology |
Animal models of human amyloidoses
|
WO1994009364A1
(en)
|
1992-10-13 |
1994-04-28 |
Duke University |
Method of inhibiting binding of amyloid precursor protein to beta-amyloid protein
|
ATE247282T1
(de)
|
1992-10-26 |
2003-08-15 |
Elan Pharm Inc |
Verfahren zur identifizierung von hemmstoffe der produktion des beta-amyloidpeptids
|
US5605811A
(en)
|
1992-10-26 |
1997-02-25 |
Athena Neurosciences, Inc. |
Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
|
US5972336A
(en)
|
1992-11-03 |
1999-10-26 |
Oravax Merieux Co. |
Urease-based vaccine against helicobacter infection
|
US6210671B1
(en)
|
1992-12-01 |
2001-04-03 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with L-selectin
|
HU221420B1
(en)
|
1993-01-22 |
2002-09-28 |
Sloan Kettering Inst Cancer |
Ganglioside-protein conjugate vaccines
|
US5955317A
(en)
|
1993-01-25 |
1999-09-21 |
Takeda Chemical Industries, Ltd. |
Antibodies to β-amyloids or their derivatives and use thereof
|
US5750349A
(en)
|
1993-01-25 |
1998-05-12 |
Takeda Chemical Industries Ltd. |
Antibodies to β-amyloids or their derivatives and use thereof
|
US5358708A
(en)
|
1993-01-29 |
1994-10-25 |
Schering Corporation |
Stabilization of protein formulations
|
US5472693A
(en)
|
1993-02-16 |
1995-12-05 |
The Dow Chemical Company |
Family of anti-carcinoembryonic antigen chimeric antibodies
|
CA2115811A1
(en)
|
1993-02-17 |
1994-08-18 |
Claus Krebber |
A method for in vivo selection of ligand-binding proteins
|
CA2115900A1
(en)
|
1993-02-22 |
1994-08-23 |
Gerald W. Becker |
Pharmaceutical screens and antibodies
|
ATE386800T1
(de)
|
1993-03-17 |
2008-03-15 |
Us Gov Health & Human Serv |
Immunogene chimäre umfassend nucleinsäuresequenzen, die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
|
WO1994021288A1
(en)
|
1993-03-18 |
1994-09-29 |
Cytimmune Sciences, Inc. |
Composition and method for reducing toxicity of biologically-active factors
|
AU685443B2
(en)
|
1993-03-23 |
1998-01-22 |
Smithkline Beecham Biologicals (Sa) |
Vaccine compositions containing 3-O deacylated monophosphoryl lipid A
|
IT1270939B
(it)
|
1993-05-11 |
1997-05-26 |
Angeletti P Ist Richerche Bio |
Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
|
ES2150493T5
(es)
|
1993-05-25 |
2004-07-01 |
Wyeth Holdings Corporation |
Adyuvantes para vacunas contra el virus sincitico respiratorio.
|
AU7043894A
(en)
|
1993-05-28 |
1994-12-20 |
Miriam Hospital, The |
Composition and method for (in vivo) imaging of amyloid deposits
|
PT700445E
(pt)
|
1993-06-04 |
2002-07-31 |
Whitehead Biomedical Inst |
Proteinas de stress e suas utilizacoes
|
US5464823A
(en)
|
1993-07-20 |
1995-11-07 |
The Regents Of The University Of California |
Mammalian antibiotic peptides
|
EP0712442B1
(en)
|
1993-07-30 |
2002-03-27 |
Medeva Holdings B.V. |
Vaccine compositions
|
EP0664814A1
(en)
|
1993-08-18 |
1995-08-02 |
MorphoSys AG |
Lipopolysaccharide-binding and neutralizing peptides
|
DK96493D0
(da)
|
1993-08-26 |
1993-08-26 |
Mouritsen Og Elsner Aps |
Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
|
AU707083B2
(en)
|
1993-08-26 |
1999-07-01 |
Bavarian Nordic Inc. |
Inducing antibody response against self-proteins with the aid of foreign T-cell epitopes
|
CA2169635C
(en)
|
1993-08-26 |
2002-11-12 |
Dennis A. Carson |
Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
|
WO1995006407A1
(en)
|
1993-08-30 |
1995-03-09 |
The Regents Of The University Of California |
Novel component of amyloid in alzheimer's disease and methods for use of same
|
UA48940C2
(uk)
|
1993-09-07 |
2002-09-16 |
Смітклайн Бічам Корпорейшн |
Рекомбінатні il4 антитіла, які використовуються для лікування il4-опосередкованих порушень
|
US5652334A
(en)
|
1993-09-08 |
1997-07-29 |
City Of Hope |
Method for design of substances that enhance memory and improve the quality of life
|
US5385887A
(en)
|
1993-09-10 |
1995-01-31 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
DK0735893T3
(da)
|
1993-09-14 |
2009-03-09 |
Pharmexa Inc |
PAN DR-bindende peptider til styrkelse af immunsvaret
|
US5470951A
(en)
|
1993-09-29 |
1995-11-28 |
City Of Hope |
Peptides for antagonizing the effects of amyloid βprotein
|
US5858981A
(en)
|
1993-09-30 |
1999-01-12 |
University Of Pennsylvania |
Method of inhibiting phagocytosis
|
JPH09506170A
(ja)
|
1993-10-20 |
1997-06-17 |
デューク・ユニヴァーシティ |
β‐アミロイドペプチドに物質を結合する方法
|
WO1995011008A2
(en)
|
1993-10-22 |
1995-04-27 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
US5744368A
(en)
|
1993-11-04 |
1998-04-28 |
Research Foundation Of State University Of New York |
Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR)
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
US5434170A
(en)
|
1993-12-23 |
1995-07-18 |
Andrulis Pharmaceuticals Corp. |
Method for treating neurocognitive disorders
|
ATE278023T1
(de)
|
1994-01-27 |
2004-10-15 |
Univ Minnesota |
Nicht humane, transgenische säugetiere mit sich entwickelnder neurologischer krankheit
|
US5877399A
(en)
|
1994-01-27 |
1999-03-02 |
Johns Hopkins University |
Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
|
AU692237B2
(en)
|
1994-02-03 |
1998-06-04 |
Picower Institute For Medical Research, The |
Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
|
AUPM411994A0
(en)
|
1994-02-25 |
1994-03-24 |
Deakin Research Limited |
Epitopes
|
US5795954A
(en)
|
1994-03-04 |
1998-08-18 |
Genentech, Inc. |
Factor VIIa inhibitors from Kunitz domain proteins
|
US6270757B1
(en)
|
1994-04-21 |
2001-08-07 |
Genetics Institute, Inc. |
Formulations for IL-11
|
US6372716B1
(en)
|
1994-04-26 |
2002-04-16 |
Genetics Institute, Inc. |
Formulations for factor IX
|
ATE202940T1
(de)
|
1994-05-25 |
2001-07-15 |
John Mcmichael |
Mittel und methoden zur behandlung von plaque- krankheiten
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
US5798100A
(en)
|
1994-07-06 |
1998-08-25 |
Immunomedics, Inc. |
Multi-stage cascade boosting vaccine
|
US6417178B1
(en)
|
1994-07-19 |
2002-07-09 |
University Of Pittsburgh |
Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
|
CA2195642A1
(en)
|
1994-07-27 |
1996-02-08 |
Andreas Suhrbier |
Polyepitope vaccines
|
AU707159B2
(en)
|
1994-09-16 |
1999-07-01 |
Cancer Research Fund Of Contra Costa |
Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
|
US5872005A
(en)
|
1994-11-03 |
1999-02-16 |
Cell Genesys Inc. |
Packaging cell lines for adeno-associated viral vectors
|
US6114133A
(en)
|
1994-11-14 |
2000-09-05 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)
|
US5589154A
(en)
|
1994-11-22 |
1996-12-31 |
Rutgers, The State University Of New Jersey |
Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease
|
US5688651A
(en)
|
1994-12-16 |
1997-11-18 |
Ramot University Authority For Applied Research And Development Ltd. |
Prevention of protein aggregation
|
EP0820299B1
(en)
|
1995-02-06 |
2002-04-24 |
Genetics Institute, Inc. |
Formulations for il-12
|
US5786180A
(en)
|
1995-02-14 |
1998-07-28 |
Bayer Corporation |
Monoclonal antibody 369.2B specific for β A4 peptide
|
US5624937A
(en)
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
US5817626A
(en)
|
1995-03-14 |
1998-10-06 |
Praecis Pharmaceuticals Incorporated |
Modulators of beta-amyloid peptide aggregation
|
US6319498B1
(en)
|
1995-03-14 |
2001-11-20 |
Praecis Pharmaceuticals Incorporated |
Modulators of amyloid aggregation
|
US6303567B1
(en)
|
1995-03-14 |
2001-10-16 |
Praecis Pharmaceuticals, Inc . |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
US5854215A
(en)
|
1995-03-14 |
1998-12-29 |
Praecis Pharmaceuticals Incorporated |
Modulators of β-amyloid peptide aggregation
|
AU711702B2
(en)
|
1995-03-23 |
1999-10-21 |
Cambridge University Technical Services Limited |
Vectors for gene delivery
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
EP0827544B1
(en)
|
1995-05-23 |
2004-08-18 |
MorphoSys AG |
Multimeric proteins
|
AU6113896A
(en)
|
1995-06-05 |
1996-12-24 |
Brigham And Women's Hospital |
Use of oral tolerance to suppress both th1 and th2 immune re sponses and to suppress antibody production
|
US5948763A
(en)
|
1995-06-07 |
1999-09-07 |
New York University |
Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
|
US5910427A
(en)
|
1995-06-22 |
1999-06-08 |
La Jolla Institute For Allergy And Immunology |
Antigen non-specific glycosylation inhibiting factor derivatives
|
ES2174027T3
(es)
|
1995-06-30 |
2002-11-01 |
American Cyanamid Co |
Composiciones estables que contienen macrolidos y macrolidos combinados con unas vacunas.
|
ATE305039T1
(de)
|
1995-07-07 |
2005-10-15 |
Darwin Molecular Corp |
Auf chromosom 1 lokalisiertes gen dessen genprodukt mit der alzheimerschen krankheit assoziiert ist.
|
AUPN443995A0
(en)
|
1995-07-27 |
1995-08-17 |
Csl Limited |
Papillomavirus polyprotein
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
EP0859841B1
(en)
|
1995-08-18 |
2002-06-19 |
MorphoSys AG |
Protein/(poly)peptide libraries
|
US5824322A
(en)
|
1995-08-21 |
1998-10-20 |
Cytrx Corporation |
Compositions and methods for growth promotion
|
AU707484B2
(en)
|
1995-09-14 |
1999-07-08 |
Regents Of The University Of California, The |
Antibodies specific for native PrPsc
|
US5731284A
(en)
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
US5985242A
(en)
|
1995-10-27 |
1999-11-16 |
Praecis Pharmaceuticals, Inc. |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
US5750361A
(en)
|
1995-11-02 |
1998-05-12 |
The Regents Of The University Of California |
Formation and use of prion protein (PRP) complexes
|
EP1281718A3
(en)
|
1995-11-10 |
2005-01-19 |
ELAN CORPORATION, Plc |
Peptides which enhance transport across tissues
|
WO1997018855A1
(en)
|
1995-11-21 |
1997-05-29 |
Eduard Naumovich Lerner |
Device for enhanced delivery of biologically active substances and compounds in an organism
|
AU1072897A
(en)
|
1995-12-12 |
1997-07-03 |
Karolinska Innovations Ab |
Peptide binding the klvff-sequence of amyloid beta
|
US6015662A
(en)
|
1996-01-23 |
2000-01-18 |
Abbott Laboratories |
Reagents for use as calibrators and controls
|
US5770700A
(en)
|
1996-01-25 |
1998-06-23 |
Genetics Institute, Inc. |
Liquid factor IX formulations
|
ZA97452B
(en)
|
1996-01-25 |
1997-08-15 |
Trinity College Dublin |
Streptococcus equi vaccine.
|
US6096313A
(en)
|
1996-02-09 |
2000-08-01 |
Ludwig Institute For Cancer Research |
Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
|
JP2000505306A
(ja)
|
1996-02-26 |
2000-05-09 |
モルフォシス・アクチェンゲゼルシャフト |
2つまたはそれ以上の相互作用性(ポリ)ペプチドをコードする核酸配列の新規同定方法
|
US6150091A
(en)
|
1996-03-06 |
2000-11-21 |
Baylor College Of Medicine |
Direct molecular diagnosis of Friedreich ataxia
|
JP2000507449A
(ja)
|
1996-03-29 |
2000-06-20 |
ユニバーシティ オブ オタゴ |
パラポックスウイルスベクター
|
US5837829A
(en)
|
1996-04-02 |
1998-11-17 |
Abbott Laboratories |
9-oximesilyl erythromycin a derivatives
|
WO1997036601A1
(en)
|
1996-04-03 |
1997-10-09 |
Anergen, Inc. |
Cyclic peptide vaccines for treatment and prevention of diabetes
|
US6838237B2
(en)
|
1996-04-19 |
2005-01-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Antigenically reactive regions of the hepatitis a virus polyprotein
|
US6284533B1
(en)
|
1996-05-01 |
2001-09-04 |
Avant Immunotherapeutics, Inc. |
Plasmid-based vaccine for treating atherosclerosis
|
JP2000516452A
(ja)
|
1996-07-16 |
2000-12-12 |
プリュックテュン,アンドレアス |
可溶性が増大した免疫グロブリンスーパーファミリードメインおよびフラグメント
|
EP0960204A4
(en)
|
1996-07-26 |
2002-01-23 |
Sloan Kettering Inst Cancer |
METHODS AND REAGENTS FOR GENETIC IMMUNIZATION
|
US7147851B1
(en)
|
1996-08-15 |
2006-12-12 |
Millennium Pharmaceuticals, Inc. |
Humanized immunoglobulin reactive with α4β7 integrin
|
CA2183901A1
(en)
|
1996-08-22 |
1998-02-23 |
Johanna E. Bergmann |
Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans
|
DK0929574T3
(da)
|
1996-08-27 |
2005-10-31 |
Praecis Pharm Inc |
Modulatorer af beta-amyloidpeptidaggregering, som omfatter D-aminosyrer
|
US6057367A
(en)
|
1996-08-30 |
2000-05-02 |
Duke University |
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
|
US6797495B2
(en)
|
1996-11-05 |
2004-09-28 |
The Regents Of The University Of California |
Somatic cells with ablated PrP gene and methods of use
|
US6022859A
(en)
|
1996-11-15 |
2000-02-08 |
Wisconsin Alumni Research Foundation |
Inhibitors of β-amyloid toxicity
|
WO1998022120A1
(en)
|
1996-11-19 |
1998-05-28 |
The Wistar Institute Of Anatomy & Biology |
Diagnostic and therapeutic reagents for alzheimer's disease
|
US6962984B2
(en)
|
1996-12-05 |
2005-11-08 |
Nihon University |
IgA nephropathy-related DNA
|
US20030068316A1
(en)
|
1997-02-05 |
2003-04-10 |
Klein William L. |
Anti-ADDL antibodies and uses thereof
|
US6218506B1
(en)
|
1997-02-05 |
2001-04-17 |
Northwestern University |
Amyloid β protein (globular assembly and uses thereof)
|
BR9811260A
(pt)
|
1997-03-03 |
2000-08-08 |
Boehringer Ingelheim Pharma |
Pequenas moléculas úteis no tratamento de doença inflamatória
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
US5798102A
(en)
|
1997-03-04 |
1998-08-25 |
Milkhaus Laboratory, Inc. |
Treatment of cardiomyopathy
|
US6057098A
(en)
|
1997-04-04 |
2000-05-02 |
Biosite Diagnostics, Inc. |
Polyvalent display libraries
|
US20020086847A1
(en)
|
1997-04-09 |
2002-07-04 |
Mindset Biopharmaceuticals (Usa) |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
AU743827B2
(en)
|
1997-04-09 |
2002-02-07 |
Intellect Neurosciences, Inc. |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
|
US6787319B2
(en)
|
1997-04-16 |
2004-09-07 |
American Home Products Corp. |
β-amyloid peptide-binding proteins and polynucleotides encoding the same
|
ATE370740T1
(de)
|
1997-05-20 |
2007-09-15 |
Ottawa Health Research Inst |
Verfahren zur herstellung von nukleinsäurekonstrukten
|
WO1998056418A1
(en)
|
1997-06-13 |
1998-12-17 |
Genentech, Inc. |
Stabilized antibody formulation
|
WO1999000150A2
(en)
|
1997-06-27 |
1999-01-07 |
Regents Of The University Of California |
Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor
|
IT1293511B1
(it)
|
1997-07-30 |
1999-03-01 |
Gentili Ist Spa |
Anticorpi monoclonali catalitici ad attivita' proteasica per la lisi selettiva della componente proteica di placche e aggregati correlati
|
EP1005569A2
(en)
|
1997-08-01 |
2000-06-07 |
MorphoSys AG |
Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
|
US7078191B1
(en)
|
1997-08-01 |
2006-07-18 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
|
JP5220248B2
(ja)
|
1997-08-29 |
2013-06-26 |
アンチジェニックス・インコーポレイテッド |
アジュバントqs−21および賦形剤としてポリソルベートまたはシクロデキストリンを含む組成物
|
US6175057B1
(en)
|
1997-10-08 |
2001-01-16 |
The Regents Of The University Of California |
Transgenic mouse model of alzheimer's disease and cerebral amyloid angiopathy
|
US7964192B1
(en)
*
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
US6787523B1
(en)
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US6710226B1
(en)
|
1997-12-02 |
2004-03-23 |
Neuralab Limited |
Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
US6923964B1
(en)
|
1997-12-02 |
2005-08-02 |
Neuralab Limited |
Active immunization of AScr for prion disorders
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
DE69831971T2
(de)
|
1997-12-03 |
2006-07-06 |
Neuralab Ltd., Flatts |
Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
|
ID28057A
(id)
|
1997-12-03 |
2001-05-03 |
Fujisawa Pharmaceutical Co |
Obat dalam bentuk pil lunak dan proses pembuatannya
|
FR2777015B3
(fr)
|
1998-02-23 |
2000-09-15 |
Financ De Biotechnologie |
Procede et moyens pour l'obtention de modeles cellulaires et animaux de maladies neurodegeneratives
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
US20050059591A1
(en)
|
1998-04-07 |
2005-03-17 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US20050059802A1
(en)
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
CA2327505A1
(en)
|
1998-04-28 |
1999-11-04 |
Smithkline Beecham Corporation |
Monoclonal antibodies with reduced immunogenicity
|
NO314086B1
(no)
|
1998-05-08 |
2003-01-27 |
Gemvax As |
Peptider og farmasöytiske sammensetninger inneholdende disse, nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slike DNA-sekvenser samt anvendelse av disse for fremstilling avfarmasöytiske preparater til
|
CA2328612A1
(en)
|
1998-05-19 |
1999-11-25 |
Yeda Research And Development Co., Ltd. |
Activated t cells, nervous system-specific antigens and their uses
|
US20030147882A1
(en)
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
EP1078005B1
(en)
|
1998-05-21 |
2010-04-21 |
University Of Tennessee Research Foundation |
Methods for amyloid removal using anti-amyloid antibodies
|
US6432710B1
(en)
|
1998-05-22 |
2002-08-13 |
Isolagen Technologies, Inc. |
Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
|
US6727349B1
(en)
|
1998-07-23 |
2004-04-27 |
Millennium Pharmaceuticals, Inc. |
Recombinant anti-CCR2 antibodies and methods of use therefor
|
DE69918146T2
(de)
|
1998-10-05 |
2005-07-07 |
Pharmexa A/S |
Verfahren zur therapeutischen impfung
|
WO2000023082A1
(en)
|
1998-10-19 |
2000-04-27 |
Yeda Research And Development Co. Ltd. |
Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
|
US7112661B1
(en)
|
1998-10-30 |
2006-09-26 |
The Research Foundation Of State University Of New York |
Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha
|
GB2348203B
(en)
|
1998-11-04 |
2002-06-19 |
Imp College Innovations Ltd |
Solube beta-forms of prion proteins, methods of preparation and use
|
ES2216509T3
(es)
|
1999-01-19 |
2004-10-16 |
PHARMACIA & UPJOHN COMPANY |
Procedimiento de envasado para sustancias medicinales sensibles a la oxidacion.
|
AU775525B2
(en)
|
1999-01-22 |
2004-08-05 |
Auckland Technology Enabling Corporation Limited |
Vaccine-mediated treatment of neurological disorders
|
US7629311B2
(en)
|
1999-02-24 |
2009-12-08 |
Edward Lewis Tobinick |
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
|
US7282570B2
(en)
|
1999-04-20 |
2007-10-16 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
WO2000068263A2
(en)
|
1999-05-05 |
2000-11-16 |
Neurochem, Inc. |
Stereoselective antifibrillogenic peptides and peptidomimetics thereof
|
US6787637B1
(en)
*
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
PE20010212A1
(es)
|
1999-06-01 |
2001-02-22 |
Neuralab Ltd |
Composiciones del peptido a-beta y procesos para producir las mismas
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
WO2000077178A1
(en)
|
1999-06-16 |
2000-12-21 |
Boston Biomedical Research Institute |
IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO
|
CA2377382A1
(en)
|
1999-07-01 |
2001-01-11 |
Scios, Inc. |
Prevention and treatment of amyloid-associated disorders
|
BR0012429A
(pt)
|
1999-07-15 |
2002-09-17 |
Genetics Inst |
Fórmulações para il-11
|
ATE445639T1
(de)
|
1999-08-04 |
2009-10-15 |
Univ Southern California |
Globularer aufbau vom amyloid-beta- protein und deren verwendungen
|
AU784568B2
(en)
|
1999-09-03 |
2006-05-04 |
Ramot At Tel-Aviv University Ltd |
Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
|
US6294171B2
(en)
|
1999-09-14 |
2001-09-25 |
Milkhaus Laboratory, Inc. |
Methods for treating disease states comprising administration of low levels of antibodies
|
US6824780B1
(en)
|
1999-10-29 |
2004-11-30 |
Genentech, Inc. |
Anti-tumor antibody compositions and methods of use
|
AU784312B2
(en)
|
1999-11-29 |
2006-03-09 |
Bellus Health (International) Limited |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
JP4804690B2
(ja)
|
1999-12-08 |
2011-11-02 |
インテレクト・ニューロサイエンシズ・インコーポレーテッド |
免疫原としてのキメラペプチド、それに対する抗体、およびキメラペプチドまたは抗体を用いた免疫法
|
US6399314B1
(en)
|
1999-12-29 |
2002-06-04 |
American Cyanamid Company |
Methods of detection of amyloidogenic proteins
|
ATE306933T1
(de)
|
2000-02-21 |
2005-11-15 |
Pharmexa As |
Verfahren zur herabregulierung von amyloid
|
CZ20022748A3
(cs)
|
2000-02-21 |
2004-03-17 |
Pharmexa A/S |
Nová metoda regulace obsahu amyloidu
|
DE60106394T3
(de)
|
2000-02-24 |
2013-07-25 |
Washington University St. Louis |
Humanisierte antikörper, die amyloid beta peptid sequestrieren
|
EP1353944A2
(en)
|
2000-04-05 |
2003-10-22 |
The University Of Tennessee Research Corporation |
Methods of investigating, diagnosing, and treating amyloidosis
|
DE60134499D1
(de)
|
2000-04-13 |
2008-07-31 |
Corixa Corp |
Immunostimulierende zusammnensetzungen die aminoalkyl glucosaminidephosphat und qs-21 enthalten
|
AU2001274873B2
(en)
|
2000-05-22 |
2006-10-05 |
New York University |
Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
|
JP5362164B2
(ja)
|
2000-07-07 |
2013-12-11 |
バイオアークティック ニューロサイエンス アーベー |
アルツハイマー病の予防及び治療
|
US20020009445A1
(en)
|
2000-07-12 |
2002-01-24 |
Yansheng Du |
Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
|
EP1172378A1
(en)
|
2000-07-12 |
2002-01-16 |
Richard Dr. Dodel |
Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
|
US20030092145A1
(en)
|
2000-08-24 |
2003-05-15 |
Vic Jira |
Viral vaccine composition, process, and methods of use
|
CA2421374C
(en)
|
2000-09-06 |
2017-03-07 |
Aventis Pharma S.A. |
Methods and compositions for diseases associated with amyloidosis
|
IT1319277B1
(it)
|
2000-10-24 |
2003-09-26 |
Chiesi Farma Spa |
Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer.
|
IL139308A0
(en)
|
2000-10-26 |
2001-11-25 |
Marikovsky Moshe |
Peptides from amyloid precursor protein which inhibit tumor growth and metastasis
|
JP2004518488A
(ja)
|
2000-11-02 |
2004-06-24 |
コーネル リサーチ ファンデーション インコーポレーテッド |
インビボ多光子診断的な神経変性疾患の検出および撮像
|
DE60126980T2
(de)
|
2000-11-27 |
2007-11-08 |
Praecis Pharmaceuticals Inc., Waltham |
Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US6900036B2
(en)
|
2000-12-27 |
2005-05-31 |
University Of Texas Health Science Center Houston |
Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers
|
US20020160394A1
(en)
|
2001-01-24 |
2002-10-31 |
Bayer Corporation |
Regulation of transthyretin to treat obesity
|
DE60121729T2
(de)
|
2001-04-19 |
2007-11-29 |
Dr. Hermann Schätzl |
Prion Proteindimere für Impfungen
|
WO2002088307A2
(en)
|
2001-04-30 |
2002-11-07 |
Eli Lilly And Company |
Humanized antibodies
|
ES2437875T3
(es)
|
2001-04-30 |
2014-01-14 |
Eli Lilly And Company |
Anticuerpos humanizados que reconocen el péptido beta-amiloide
|
US6906169B2
(en)
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
AU2002345843A1
(en)
|
2001-06-22 |
2003-01-08 |
Panacea Pharmaceuticals, Inc. |
Compositions and methods for preventing protein aggregation in neurodegenerative diseases
|
DE60235013D1
(de)
|
2001-07-25 |
2010-02-25 |
Facet Biotech Corp |
Stabile lyophilisierte pharmazeutische formulierung des igg-antikörpers daclizumab
|
US20030135035A1
(en)
|
2001-08-09 |
2003-07-17 |
Mark Shannon |
Human ZZAP1 protein
|
AU2002324468A1
(en)
|
2001-08-17 |
2003-03-03 |
Eli Lilly And Company |
Rapid improvement of cognition in conditions related to abeta
|
EP1432444A4
(en)
|
2001-08-17 |
2005-11-02 |
Lilly Co Eli |
ANTI-BETA ANTIBODIES
|
JP2005500389A
(ja)
|
2001-08-17 |
2005-01-06 |
イーライ・リリー・アンド・カンパニー |
Aβに関連する病態および疾患を治療するための、可溶性Aβに高い親和性を有する抗体の使用
|
US20030082191A1
(en)
|
2001-08-29 |
2003-05-01 |
Poduslo Joseph F. |
Treatment for central nervous system disorders
|
US6907297B2
(en)
|
2001-09-28 |
2005-06-14 |
Ethicon, Inc. |
Expandable intracardiac return electrode and method of use
|
US7781413B2
(en)
|
2001-10-31 |
2010-08-24 |
Board Of Regents, The University Of Texas System |
SEMA3B inhibits tumor growth and induces apoptosis in cancer cells
|
CN1292655C
(zh)
|
2001-11-08 |
2007-01-03 |
蛋白质设计实验室股份有限公司 |
IgG抗体稳定的液态药物制剂
|
AU2002357007A1
(en)
|
2001-11-21 |
2003-06-10 |
New York University |
SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID Beta, PRION PROTEIN, AMYLIN, Alpha-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO
|
US20050227941A1
(en)
|
2001-12-17 |
2005-10-13 |
Karen Duff |
Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases
|
AR038568A1
(es)
|
2002-02-20 |
2005-01-19 |
Hoffmann La Roche |
Anticuerpos anti-a beta y su uso
|
AU2003224624B2
(en)
|
2002-02-21 |
2008-08-28 |
Duke University |
Reagents and treatment methods for autoimmune diseases
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
DE60336902D1
(de)
|
2002-07-19 |
2011-06-09 |
Cytos Biotechnology Ag |
Impfstoffzusammensetzungen enthaltende amyloid beta 1-6 antigenarrays
|
EP1911765A3
(en)
|
2002-07-24 |
2008-04-23 |
Innogenetics N.V. |
Prevention, treatment and diagnosis of diseases associated with Beta-Amyloid formation and/or aggregation
|
JP2006508072A
(ja)
|
2002-10-01 |
2006-03-09 |
ノースウエスタン ユニバーシティ |
アミロイドベータ由来拡散性リガンド(ADDLs)、ADDL代替物、ADDL結合性分子、およびそれらの使用
|
US20060019850A1
(en)
*
|
2002-10-31 |
2006-01-26 |
Korzenski Michael B |
Removal of particle contamination on a patterned silicon/silicon dioxide using dense fluid/chemical formulations
|
FR2846667B1
(fr)
|
2002-11-06 |
2004-12-31 |
Pasteur Institut |
Fragments variables d'anticorps de camelides a chaine unique diriges contre le peptide beta-amyloide 1-42 et leurs applications pour le diagnostic et le traitement des maladies neuroagregatives
|
AU2003293543A1
(en)
|
2002-12-13 |
2004-07-09 |
Abgenix, Inc. |
System and method for stabilizing antibodies with histidine
|
AU2004209981B2
(en)
|
2003-02-01 |
2009-02-26 |
Janssen Sciences Ireland Uc |
Active immunization to generate antibodies to soluble A-beta
|
ES2344645T3
(es)
|
2003-02-10 |
2010-09-02 |
Applied Molecular Evolution, Inc. |
Moleculas de union al abeta.
|
PL2335725T3
(pl)
|
2003-04-04 |
2017-04-28 |
Genentech, Inc. |
Preparaty zawierające wysokoskoncentrowane przeciwciała i białka
|
EP1480041A1
(en)
|
2003-05-22 |
2004-11-24 |
Innogenetics N.V. |
Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
WO2005002444A1
(en)
|
2003-07-07 |
2005-01-13 |
Agency For Science, Technology And Research |
Method and apparatus for extracting third ventricle information
|
WO2005014041A2
(en)
|
2003-07-24 |
2005-02-17 |
Novartis Ag |
Use of an amyloid beta dna vaccine for the treatment and/or prevention of amyloid diseases
|
WO2005026211A2
(en)
|
2003-09-05 |
2005-03-24 |
Eli Lilly And Company |
Anti-ghrelin antibodies
|
CA2445743A1
(en)
|
2003-10-08 |
2005-04-08 |
The University Of British Columbia |
Methods for modulating neuronal responses
|
TWI379839B
(en)
|
2003-12-17 |
2012-12-21 |
Wyeth Llc |
Aβ immunogenic peptide carrier conjugates and methods of producing same
|
WO2005058940A2
(en)
|
2003-12-17 |
2005-06-30 |
Wyeth |
Immunogenic peptide carrier conjugates and methods of producing same
|
US20050214222A1
(en)
|
2004-02-13 |
2005-09-29 |
Mckinnon Stuart J |
In vivo imaging of amyloid plaques in glaucoma using intravenous injectable dyes
|
EP2298744B1
(en)
|
2004-03-15 |
2013-06-26 |
Janssen Pharmaceutica NV |
Opioid receptor modulators
|
ES2427963T3
(es)
|
2004-07-02 |
2013-11-05 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Uso de derivados de tioflavina radiomarcados en formación de imágenes de amiloide para evaluación de las terapias antiamiloide
|
NZ552480A
(en)
|
2004-07-30 |
2010-01-29 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide and methods of using same
|
US20090247931A1
(en)
|
2004-09-23 |
2009-10-01 |
Novo Nordisk A/S |
Device for self-care support
|
EP1828251B1
(en)
|
2004-10-05 |
2012-09-26 |
Janssen Alzheimer Immunotherapy |
Methods and compositions for improving recombinant protein production
|
WO2006047670A2
(en)
|
2004-10-26 |
2006-05-04 |
Wyeth |
Methods for assessing antibodies to neurodegenerative disease-associated antigens
|
US20060257396A1
(en)
|
2004-12-15 |
2006-11-16 |
Jacobsen Jack S |
Abeta antibodies for use in improving cognition
|
WO2006066233A1
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
An immunoprecipitation-based assay for predicting in vivo efficacy of beta-amyloid antibodies
|
PE20061152A1
(es)
|
2004-12-15 |
2006-10-13 |
Neuralab Ltd |
Anticuerpos humanizados que reconocen el peptido beta amiloideo
|
WO2006066118A2
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Contextual fear test for predicting efficacy of alzheimer immunotherapeutic treatment
|
US8916165B2
(en)
|
2004-12-15 |
2014-12-23 |
Janssen Alzheimer Immunotherapy |
Humanized Aβ antibodies for use in improving cognition
|
MX2007009091A
(es)
|
2005-01-28 |
2008-01-11 |
Wyeth Corp |
Formulaciones de polipeptido liquidas estabilizadas.
|
GT200600031A
(es)
*
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
NZ562434A
(en)
|
2005-05-05 |
2010-04-30 |
Merck & Co Inc |
Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
|
MY144484A
(en)
|
2005-06-17 |
2011-09-30 |
Wyeth Corp |
Methods of purifying anti a beta antibodies
|
ATE550338T1
(de)
|
2005-07-18 |
2012-04-15 |
Merck Sharp & Dohme |
Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
|
KR20080095836A
(ko)
|
2005-11-10 |
2008-10-29 |
로스캄프 리서치 엘엘씨 |
A―베타 펩티드 단편에 의한 혈관형성의 조정
|
PT1996621E
(pt)
|
2006-03-30 |
2010-03-08 |
Glaxo Group Ltd |
Anticorpos contra o péptido beta-amilóide
|
WO2009017467A1
(en)
|
2007-07-27 |
2009-02-05 |
Elan Pharma International Limited |
Treatment of amyloidogenic diseases
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
WO2010044803A1
(en)
|
2008-10-17 |
2010-04-22 |
Elan Pharma International Limited |
Treatment of amyloidogenic diseases
|
CA2657681C
(en)
|
2006-07-14 |
2019-03-19 |
Ac Immune S.A. |
Humanized antibodies against beta amyloid protein
|
CA2680762A1
(en)
|
2007-03-12 |
2008-09-25 |
National Institute Of Radiological Sciences |
Pet visualization of amyloid-associated neuroinflammation in the brain
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
WO2008131298A2
(en)
|
2007-04-18 |
2008-10-30 |
Elan Pharma International Limited |
Prevention and treatment of cerebral amyloid angiopathy
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
WO2011133919A1
(en)
|
2010-04-22 |
2011-10-27 |
Janssen Alzheimer Immunotherapy |
Use of tau to monitor immunotherapy
|
EA036059B1
(ru)
|
2007-12-28 |
2020-09-21 |
Протена Байосайенсиз Лимитед |
Способ получения антитела или его фрагмента, которое специфически связывается с агрегированным амилоидным белком
|
PT2323696T
(pt)
|
2008-09-18 |
2018-11-20 |
Cedars Sinai Medical Center |
Método ótico para a deteção da doença de alzheimer
|
WO2011106732A1
(en)
|
2010-02-25 |
2011-09-01 |
Wyeth Llc |
Pet monitoring of ab-directed immunotherapy
|